A team of Geisel researchers will receive funding from the Patient-Centered Outcomes Research Institute (PCORI) to design new methods for comparing the effectiveness of alternative therapies that can lead to improvements in practice and better outcomes for patients.
Dartmouth ranks highly in a new measure of the impact of academic research on global innovation, according to the Nature Index 2017 Innovation supplement. The index examines how often research articles from top science journals are cited in third-party patents around the world.
Michael Sporn, MD, emeritus professor of pharmacology and toxicology, and medicine, is featured in Nature Index 2017 for his tremendous impact upon biomedical research and drug development.
Morgan Gilman, a fourth-year graduate student in the McLellan Lab at Geisel, is helping lead efforts to understand how a particular type of protein allows deadly viruses—such as Ebola and RSV (respiratory syncytial virus)—to gain entry into host cells, and how antibodies can be developed to neutralize that process.
Dartmouth-led research is in early phase drug discovery and finds promising therapeutic leads after targeting vulnerabilities in nervous system tumors, including glioblastoma.
The scholar is funded by an endowment established by world-renowned ophthalmologist and Dartmouth alumnus Francis A. L’Esperance, Jr., MD, (MED’54), which supports research in ophthalmology and diseases of the eye.
More than $12 million over five years has been awarded for research collaboration to more precisely determine lung cancer risk and improve screening.
A team of Dartmouth researchers has found that mothers who have developed antibodies against the herpes simplex virus (HSV-1) can pass these antibodies to the nervous systems of their infants, protecting them from acquiring the virus.
Physician and scientist Steven D. Leach, MD, has been selected as the new Director of the Norris Cotton Cancer Center. The appointment was announced today by Dr. Duane Compton, dean of the Geisel School of Medicine at Dartmouth, and Dr. James N. Weinstein, CEO and President of Dartmouth-Hitchcock.
William Wickner, MD, a professor of biochemistry and cell biology, recently received the William C. Rose Award from the American Society for Biochemistry and Molecular Biology.